Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)

NCT00074750 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Acute Myelogenous Leukemia
Chronic Myelomonocytic Leukemia

Interventions

DRUG: DTGM

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]